Literature DB >> 31578253

Mapping low-affinity/high-specificity peptide-protein interactions using ligand-footprinting mass spectrometry.

Benjamin W Parker1, Edward J Goncz1, David T Krist2, Alexander V Statsyuk2,3, Alexey I Nesvizhskii4,5, Eric L Weiss6.   

Abstract

Short linear peptide motifs that are intracellular ligands of folded proteins are a modular, incompletely understood molecular interaction language in signaling systems. Such motifs, which frequently occur in intrinsically disordered protein regions, often bind partner proteins with modest affinity and are difficult to study with conventional structural biology methods. We developed LiF-MS (ligand-footprinting mass spectrometry), a method to map peptide binding sites on folded protein domains that allows consideration of their dynamic disorder, and used it to analyze a set of D-motif peptide-mitogen-activated protein kinase (MAPK) associations to validate the approach and define unknown binding structures. LiF-MS peptide ligands carry a short-lived, indiscriminately reactive cleavable crosslinker that marks contacts close to ligand binding sites with high specificity. Each marked amino acid provides an independent constraint for a set of directed peptide-protein docking simulations, which are analyzed by agglomerative hierarchical clustering. We found that LiF-MS provides accurate ab initio identification of ligand binding surfaces and a view of potential binding ensembles of a set of D-motif peptide-MAPK associations. Our analysis provides an MKK4-JNK1 structural model, which has thus far been crystallographically unattainable, a potential alternate binding mode for part of the NFAT4-JNK interaction, and evidence of bidirectional association of MKK4 peptide with ERK2. Overall, we find that LiF-MS is an effective noncrystallographic way to understand how short linear motifs associate with specific sites on folded protein domains at the level of individual amino acids.

Entities:  

Keywords:  MAP kinases; disordered protein; docking interactions; mass spectrometry; peptide ligands

Year:  2019        PMID: 31578253      PMCID: PMC6800362          DOI: 10.1073/pnas.1819533116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

2.  Attributes of short linear motifs.

Authors:  Norman E Davey; Kim Van Roey; Robert J Weatheritt; Grischa Toedt; Bora Uyar; Brigitte Altenberg; Aidan Budd; Francesca Diella; Holger Dinkel; Toby J Gibson
Journal:  Mol Biosyst       Date:  2011-09-12

3.  Structure of full-length p53 tumor suppressor probed by chemical cross-linking and mass spectrometry.

Authors:  Christian Arlt; Christian H Ihling; Andrea Sinz
Journal:  Proteomics       Date:  2015-04-21       Impact factor: 3.984

Review 4.  A million peptide motifs for the molecular biologist.

Authors:  Peter Tompa; Norman E Davey; Toby J Gibson; M Madan Babu
Journal:  Mol Cell       Date:  2014-07-17       Impact factor: 17.970

5.  An Integrated Mass Spectrometry Based Approach to Probe the Structure of the Full-Length Wild-Type Tetrameric p53 Tumor Suppressor.

Authors:  Christian Arlt; Vanessa Flegler; Christian H Ihling; Mathias Schäfer; Iris Thondorf; Andrea Sinz
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-29       Impact factor: 15.336

Review 6.  Diazirine based photoaffinity labeling.

Authors:  Luba Dubinsky; Bastiaan P Krom; Michael M Meijler
Journal:  Bioorg Med Chem       Date:  2011-06-29       Impact factor: 3.641

7.  A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.

Authors:  David T Ho; A Jane Bardwell; Mahsa Abdollahi; Lee Bardwell
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

Review 8.  SH3 domains: complexity in moderation.

Authors:  B J Mayer
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

9.  Structural Basis for the Subversion of MAP Kinase Signaling by an Intrinsically Disordered Parasite Secreted Agonist.

Authors:  Erika Pellegrini; Andrés Palencia; Laurence Braun; Ulrike Kapp; Alexandre Bougdour; Hassan Belrhali; Matthew W Bowler; Mohamed-Ali Hakimi
Journal:  Structure       Date:  2016-11-23       Impact factor: 5.006

10.  Rapid Mapping of Protein Interactions Using Tag-Transfer Photocrosslinkers.

Authors:  Jim E Horne; Martin Walko; Antonio N Calabrese; Mark A Levenstein; David J Brockwell; Nikil Kapur; Andrew J Wilson; Sheena E Radford
Journal:  Angew Chem Int Ed Engl       Date:  2018-11-21       Impact factor: 15.336

View more
  5 in total

Review 1.  Is There a Need for a More Precise Description of Biomolecule Interactions to Understand Cell Function?

Authors:  Pierre Bongrand
Journal:  Curr Issues Mol Biol       Date:  2022-01-21       Impact factor: 2.976

2.  ADAMTS4-specific MR probe to assess aortic aneurysms in vivo using synthetic peptide libraries.

Authors:  Jan O Kaufmann; Julia Brangsch; Avan Kader; Jessica Saatz; Dilyana B Mangarova; Martin Zacharias; Wolfgang E Kempf; Timm Schwaar; Marco Ponader; Lisa C Adams; Jana Möckel; Rene M Botnar; Matthias Taupitz; Lars Mägdefessel; Heike Traub; Bernd Hamm; Michael G Weller; Marcus R Makowski
Journal:  Nat Commun       Date:  2022-05-23       Impact factor: 17.694

3.  On the specificity of protein-protein interactions in the context of disorder.

Authors:  Kaare Teilum; Johan G Olsen; Birthe B Kragelund
Journal:  Biochem J       Date:  2021-06-11       Impact factor: 3.857

Review 4.  Structural Proteomics Methods to Interrogate the Conformations and Dynamics of Intrinsically Disordered Proteins.

Authors:  Rebecca Beveridge; Antonio N Calabrese
Journal:  Front Chem       Date:  2021-03-11       Impact factor: 5.221

Review 5.  Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions.

Authors:  Pavel V Ershov; Yuri V Mezentsev; Alexis S Ivanov
Journal:  Biomolecules       Date:  2022-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.